Health Insurance Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Erasmus University, Netherlands
Patients with mesothelioma experience immunosuppression
August 13th, 2006
Patients with mesothelioma experience immunosuppression. According to recent research from the Netherlands, "Malignant mesothelioma is a cancer with dismal prognosis. The objective of the present study was to address the role of the immune system, tumor microenvironment and potential immunosuppression in mesothelioma." "Expression profiles of 80 cytokines were determined in the supernatant of mesothelioma cell lines and the original patient's pleural effusion. Influx of immune effector cells was detected by immunohistochemistry. Angiogenin, vascular endothelial growth factor, transforming growth factor-beta, epithelial neutrophil-activating...
Source: Health Insurance Law Weekly (2006-08-13)
|
